The homogeneous elevation of peri-tumoural SFA could be positioned to facilitate early detection of breast cancer [28, 31], particularly valuable in screening high-risk BRCA1/2 genetic mutation carriers prone to deregulation in lipid saturation [13]. This evidence concerns the gene BRCA1 and breast carcinoma.